Mehabe score: 7 G Factor: 5 Piotski Score: 9 The stock has a rating . The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 5 and Piotski score of 9.
Description
Thirumalai Chemicals is engaged in the Business of Phthalic Anhydride,Food ingredients and fine products,Fine and personal care ingredients.Site:TIRUMALCHMMain Symbol:TIRUMALCHM
Stock trades at 169.0, above its 50dma 139.15. It also trades above its 200dma 107.58. The stock remains bullish on techicals
The 52 week high is at 181.00 and the 52week low is at 52.40
Price Chart
P/E Chart
Sales and Margin
Strengths
–
Weakness
– The company has delivered a poor sales growth of 2.92% over past five years.
– has a low return on equity of 12.72% for last 3 years.
-Dividend payout has been low at 12.39% of profits over last 3 years
Competition
– The industry trades at a mean P/E of 30.9x. Pidilite Inds. trades at the industry’s max P/E of 104.02x. TIRUMALCHM trades at a P/E of 14.7x
– Industry’s mean G-Factor is 3.4 while the mean Piotski score is 9.0. TIRUMALCHM has a G-Factor of 5 and Piotski scoreof 9.
– Average 1 month return for industry is 9.2%. The max 1- month return was given by Thirumalai Chem.: a return of 25.85 %
Quarterly Results
Sales for period ended Jun 2021 is Rs 397.0 cr compared to Rs 113.0 cr for period ended Jun 2020, a rise of 251.3%
Company reported operating profit of Rs 102.0 cr for period ended Jun 2021, operating profit margin at 25.7 %.
Operating profit was negative for the same period last year thus company has improved its margins this year
The EPS for Jun 2021 was Rs 6.36 compared to Rs 8.27 for previous quarter ended Mar 2021 and Rs -1.96 for Jun 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 1369.0 cr for period ended TTM vis-vis sales of Rs 1086.0 cr for the period ended Mar 2021, a healthy growth of 20.7%. The 3 year sales cagr stood at 2.8%.
Operating margins expanded to 24.0% for period ended TTM vis-vis 20.0% for period ended Mar 2021, expansion of 400.0 bps.
Net Profit reported at Rs 203.0 cr for period ended TTM vis-vis sales of Rs 118.0 cr for the period ended Mar 2021, rising 41.9%.
Company recorded a healthy Net Profit CAGR of 21.2% over the last 3 years
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
CashFlow from operating activities was positive.
CashFlow from operating activities: Rs 221.0 cr for period ended Mar 2021 vis-vis Rs 140.0 cr for period ended Mar 2020
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The stock has given a return of 185% on a 1 Year basis vis-vis a return of 8% over the last 3 Years. – The compounded sales growth on a TTM bassis is 0% vis-vis a compounded sales growth of -6% over the last 3 Years. – The compounded profit growth on a TTM basis is 425% vis-vis a compounded profit growth of -12% over the last 3 Years.
Ratios
Shareholding Pattern
– FII shareholding has remained largely constant. The Jun 2021 fii holding stood at 0.34% vis-vis 0.27% for Mar 2021 – Public shareholding has remained largely constant. The Jun 2021 public holding stood at 57.05% vis-vis 57.13% for Mar 2021
Conclusion
– – The company has delivered a poor sales growth of 2.92% over past five years.
– has a low return on equity of 12.72% for last 3 years.
-Dividend payout has been low at 12.39% of profits over last 3 years
